Could a common gout drug ease thyroid inflammation?
NCT ID NCT07571681
First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times
Summary
This study tests whether low-dose colchicine, a drug used for gout, can reduce inflammation and symptoms in people with autoimmune or subacute thyroiditis. About 300 adults will be randomly assigned to colchicine, corticosteroids, or supportive care. The goal is to see if colchicine offers a safer, effective alternative to steroids for managing thyroid pain and inflammation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HASHIMOTO THYROIDITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mansoura University
RECRUITINGAl Mansurah, Dakahlia Governorate, 35516, Egypt
-
Saudi German Hospital
RECRUITINGJeddah, Mecca Region, 21461, Saudi Arabia
More trials for these conditions
Other studies related to the condition(s) this trial covers.